The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the American Joint Committee on Cancer staging system

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 3, 2008, Pages 605-610

  Flores, Raja M ^a   Routledge, Tom ^a   Seshan, Venkatraman E ^a   Dycoco, Joseph ^a   Zakowski, Maureen ^a   Hirth, Yael ^a   Rusch, Valerie W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PLEURA MESOTHELIOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODES; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS;

EID: 52049092515     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.02.069     Document Type: Article

References (27)

1. American Joint Committee on Cancer. In: Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., and Haller D.G. (Eds). AJCC Cancer Staging Handbook. 6th ed. (2002), Springer-Verlag, New York
2. Allen K.B., Faber L.P., and Warren W.H. Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy. Chest Surg Clin N Am 4 (1994) 113-126
3. Boutin C., Rey F., Gouvernet J., Viallat J.-R., Astoul P., and Ledoray V. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging. Cancer 72 (1993) 394-404
4. Butchart E.G., Ashcroft T., Barnsley W.C., and Holden M.P. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31 (1976) 15-24
5. Ruffie P., Feld R., Minkin S., Cormier Y., Boutan-Laroze A., Ginsberg R., et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 7 (1989) 1157-1168
6. Sugarbaker D.J., Strauss G.M., Lynch T.J., Richards W., Mentzer S.J., Lee T.H., et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 11 (1993) 1172-1178
7. Rusch V.W., Piantadosi S., and Holmes E.C. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 102 (1991) 1-9
8. Pass H.I., Temeck B.K., Kranda K., Steinberg S.M., and Feuerstein I.R. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 115 (1998) 310-318
9. Pass H.I., Temeck B.K., Kranda K., Thomas G., Russo A., Smith P., et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 4 (1997) 628-633
10. Rusch V.W., and Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 111 (1996) 815-826
11. Rusch V.W., and Venkatraman E.S. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68 (1999) 1799-1804
12. Tammilehto L. Malignant mesothelioma: prognostic factors in a prospective study of 98 patients. Lung Cancer 8 (1992) 175-184
13. Rusch V.W. The International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 108 (1995) 1122-1128
14. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., Richards W.G., Strauss G.M., Corson J.M., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results of 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-65
15. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
16. Parungo C.P., Colson Y.L., Kim S.-W., Kim S., Cohn L.H., Bawendi M.G., et al. Sentinel lymph node mapping of the pleural space. Chest 127 (2005) 1799-1804
17. Parungo C.P., Ohnishi S., De Grand A.M., Laurence R.G., Soltesz E.G., Colson Y.L., et al. In vivo optical imaging of pleural space drainage to lymph nodes of prognostic significance. Ann Surg Oncol 11 (2004) 1085-1092
18. Okiemy G., Foucault C., Avisse C., Hidden G., and Riquet M. Lymphatic drainage of the diaphragmatic pleura to the peritracheobronchial lymph nodes. Surg Radiol Anat 35 (2003) 32-35
19. Edwards J.G., Stewart D.J., Martin-Ucar A., Muller S., Richards C., and Waller D.A. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma. J Thorac Cardiovasc Surg 131 (2006) 981-987
20. de Perrot M., Uy K., Anraku M., Tsao M.-S., Darling G., Waddell T.K., et al. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 133 (2007) 111-116
21. Aziz T., Jilaihawi A., and Prakash D. The management of malignant pleural mesothelioma: single centre experience in 10 years. Eur J Cardiothorac Surg 22 (2002) 298-305
22. Flores R.M., Krug L.M., Rosenzweig K.E., Venkatraman E., Vincent A., Heelan R., et al. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 1 (2006) 289-295
23. Weder W., Kestenholz P., Taverna C., Bodis S., Lardinois D., Jerman M., et al. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 22 (2004) 3451-3457
24. Okamoto H., Watanabe K., Nagatomo A., Kunikane H., Aono H., Yamagata T., et al. Endobronchial ultrasonography for mediastinal and hilar lymph node metastases of lung cancer. Chest 121 (2002) 1498-1506
25. Annema J.T., Versteegh M.I., Veseliτ M., Welker L., Mauad T., Sont J.K., et al. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. J Am Med Assoc 294 (2005) 931-936
26. Vogelzang N.J., Rusthoven J., Symanowski J., Denham C., Kaukel E., Ruffie P., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (2003) 2636-2644
27. Schouwink J.H., Kool L.S., Rutgers E.J., Zoetmulder F.A., Van Zandwijk N., de Vijver M.J., et al. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thorac Surg 75 (2003) 1715-1719